Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress

被引:29
|
作者
Maziere, Cecile [1 ]
Gomila, Cathy
Maziere, Jean-Claude
机构
[1] CHU Nord, Biochem Lab, F-80000 Amiens, France
关键词
Oxidized LDL; Osteopontin; Inflammation; Oxidative stress; Atherosclerosis; Free radicals; SMOOTH-MUSCLE-CELLS; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; MACROPHAGE INFILTRATION; TRANSGENIC MICE; ANGIOTENSIN-II; T-CELLS; ATHEROSCLEROSIS; FIBROBLASTS;
D O I
10.1016/j.freeradbiomed.2010.02.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteopontin (OPN) is an important mediator of inflammation and is involved in the generation of atherosclerotic lesions. Oxidized LDL (OxLDL) increased the intracellular and secreted levels of OPN in rat smooth muscle cells in a dose- and time-dependent manner. Experiments with kinase inhibitors demonstrated that this effect was mediated by ERK and JNK, but not p38. OxLDL induced oxidative stress, measured by the intracellular levels of reactive oxygen species (ROS) and lipid peroxidation products. The increase in OPN levels was reproduced by the lipid extract of the particle and prevented by the antioxidant vitamin E. Furthermore, ROS generated by UVA irradiation or treatment with pro-oxidant compounds such as buthionine sulfoximine or H(2)O(2) also enhanced intracellular and secreted OPN. Finally, OxLDL also augmented OPN levels in other cell types such as fibroblasts, keratinocytes, and endothelial cells. This work demonstrates the role of OxLDL in the expression of the OPN gene and further highlights the role of oxidative stress in the regulation of this cytokine. This might be related to the proinflammatory effects of OxLDL in the initiation and progression of atherosclerotic plaque. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:1382 / 1387
页数:6
相关论文
共 50 条
  • [41] Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress
    Maziere, Cecile
    Salle, Valery
    Gomila, Cathy
    Maziere, Jean-Claude
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (02) : 295 - 299
  • [42] We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis
    Orekhov, Alexander N.
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [43] Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein
    Hirano, R
    Kondo, K
    Iwamoto, T
    Igarashi, O
    Itakura, H
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 1997, 43 (04) : 435 - 444
  • [44] Copper and cell-oxidized low-density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells
    Maziere, C
    DjavaheriMergny, M
    FreyFressart, V
    Delattre, J
    Maziere, JC
    FEBS LETTERS, 1997, 409 (03) : 351 - 356
  • [45] Oxidized low-density lipoprotein decreases VEGFR2 expression in HUVECs and impairs angiogenesis
    Zhang, Min
    Jiang, Li
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 3742 - 3748
  • [46] Concentration Polarization of Oxidative Modification of Low-Density Lipoproteins: Its Effect on Oxidative Modification of Low-Density Lipoprotein Uptake and Apoptosis of the Endothelial Cells
    Ding, Zufeng
    Fan, Yubo
    Deng, Xiaoyan
    ASAIO JOURNAL, 2010, 56 (05) : 468 - 474
  • [47] Oxidized low density lipoprotein, stem cells, and atherosclerosis
    Yang, Hui
    Mohamed, Ahmed Salah Salem
    Zhou, Sheng-hua
    LIPIDS IN HEALTH AND DISEASE, 2012, 11
  • [48] Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it
    Shaw, PX
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2004, 52 (04) : 225 - 239
  • [49] Oxidized Low-Density Lipoprotein Promotes In Vitro Calcification
    Yamashita, Mamiko
    Nomura, Yoshiaki
    Ishikawa, Misao
    Shimoda, Shinji
    Hanada, Nobuhiro
    MATERIALS, 2020, 13 (22) : 1 - 12
  • [50] Circulating oxidized low-density lipoprotein is increased in hypertension
    Frostegård, J
    Wu, RH
    Lemne, C
    Thulin, T
    Witztum, JL
    De Faire, U
    CLINICAL SCIENCE, 2003, 105 (05) : 615 - 620